Showing 1,601 - 1,620 results of 122,881 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.96s Refine Results
  1. 1601
  2. 1602
  3. 1603

    Image_2_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF by Santiago Castro-Zaballa (6238823)

    Published 2019
    “…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”
  4. 1604

    Image_1_EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.TIF by Santiago Castro-Zaballa (6238823)

    Published 2019
    “…Because of this fact, REM sleep is considered a natural model of psychosis. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that at sub-anesthetic dose induces psychotomimetic-like effects in humans and animals, and is employed as a pharmacological model of psychosis. …”
  5. 1605

    Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome by Azharuddin Sajid Syed Khaja (199670)

    Published 2011
    “…<div><h3>Background</h3><p>Wnt5a is a non-canonical secreted glycoprotein of the Wnt family that plays an important role in cancer development and progression. …”
  6. 1606
  7. 1607
  8. 1608
  9. 1609
  10. 1610

    Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  11. 1611

    Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  12. 1612

    Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  13. 1613

    Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  14. 1614

    Activation of mitoK<sub>ATP</sub> channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

    Published 2013
    “…The holding potential for both cells was -80 mV. ‘‘a’’ indicates the onset time point of the voltage steps. …”
  15. 1615
  16. 1616

    A Non-Coding RNA Promotes Bacterial Persistence and Decreases Virulence by Regulating a Regulator in <i>Staphylococcus aureus</i> by Cédric Romilly (251826)

    Published 2014
    “…Several non-coding RNAs carry a C-rich sequence suggesting that they regulate mRNAs at the post-transcriptional level. …”
  17. 1617
  18. 1618
  19. 1619
  20. 1620

    Subgroup analyses of the association between decreases in serum UA levels and poor functional outcome at 3 months. by Kuniyuki Nakamura (13040299)

    Published 2023
    “…<p>The ORs and 95% CIs of poor functional outcome (defined as an mRS score of 3–6 at 3 months) are shown according to UA decrease rate grade (G1 to G4) in each subgroup. The subgroups included (<b>A</b>) age (<75 or ≥75 years), (<b>B</b>) sex (women or men), (<b>C</b>) stroke subtype (non-cardioembolic or cardioembolic), (<b>D</b>) neurological severity (NIHSS <5 or ≥5), (<b>E</b>) CKD (presence or absence), and (<b>F</b>) UA level on admission (<292 or ≥292 μmol/L for women, <351 or ≥351 μmol/L for men). …”